Dr. DeAngelis came to Memorial Sloan-Kettering Cancer Center as a fellow in neuro-oncology and joined the faculty in 1986.  She became Chair of the Department of Neurology in 1997.  She holds the Lillian Rojtman Berkman Chair in honor of Dr. Jerome Posner and is also the Co-executive Director of the MSKCC Brain Tumor Center.  Dr. DeAngelis has published extensively on a wide variety of topics in neuro-oncology and is the author with Dr. Jerome Posner of The Neurological Complications of Cancer.  Dr. DeAngelis is a Fellow of the American Academy of Neurology (AAN) and of the American Neurological Association (ANA) where she served as first Vice President.  She is currently on the Board of Directors of the AAN  and recently completed 2 terms as Vice-President.  She has been the Chair of the Science Committee since 2011 and continues to serve in that capacity.  She has served on numerous committees of the ANA, AAN and the American Society of Clinical Oncology (ASCO).  She is a member of the editorial board of Neurology, Neuro-oncology and Journal of Neuro-Oncology.  She has received awards for her work including the 2009 Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.  She has been a visiting professor in numerous universities throughout the United States and internationally.  Dr. DeAngelis has recently been elected as a member of the Institute of Medicine of the National Academies. 

 

Medical Director, Maryland Proton Treatment Center, USA
Associate Director of Clinical Research, Department of Radiation Oncology, University of Maryland School of Medicine, USA
   
Minesh Mehta, M.B.Ch.B., received his medical degree from the University of Zambia in 1981 and after completing an initial internship, he proceeded to complete residency training in Radiation Oncology at the University of Wisconsin in 1988, following which he was appointed to the faculty of the University of Wisconsin's School of Medicine in the Department of Human Oncology. In 1997, he was appointed as the Chairman of the Department of Human Oncology, which he led for the subsequent 10 years.

During this time period, he rose to the rank of Professor with Tenure, and raised the Department to national recognition through an intensive phase of growth in research funding, publications output, technology development, faculty hires and growth, programmatic development, and patient services expansion at a statewide level, creating a broad cancer services network. He was instrumental in multiple refunding cycles of the Imaging and Radiation Sciences Program of the University of Wisconsin Cancer Center, PI of several grants, including a Program Project PO1 grant, and several others. He has successfully lead the RTOG Brain Tumor Program for over 15 years, with continuous grant refunding. From 2010-12, Dr. Mehta was Professor of Radiation Oncology at Northwestern University where he was also co-leader of the Lurie Cancer Center's Solid Tumor Investigational Program.

Dr. Mehta's clinical activities have revolved around thoracic and central nervous system tumors where he has gained international recognition and acclaim, based on his clinical and academic productivity, which includes several hundred manuscripts, abstracts, book chapters, and speaker invitations. He has developed robust clinical research programs with an eye toward generating level 1, practice-changing evidence. His research has also include several innovations in areas including radiosensitizers, radioprotectors, radiation oncology technology, specifically intensity modulated, image-guided radiation therapy, etc.

Dr. Mehta has had several leadership responsibilities, including Departmental Chairmanship, residency program directorship, medical school course directorship, leadership in several national organizations such as ASCO, ASTRO, SNO, ABS, ISRS, FDA, etc. He has also been very active in medical student, graduate student, and resident education.

Associate Professor Kate Drummond, MD MBBS, graduated from the University of Sydney in 1988 and trained in Neurosurgery at Westmead and Royal North Shore Hospitals in Sydney and the Austin Hospital and the Royal Children’s Hospital in Melbourne. She furthered her training with both clinical and research fellowships in Neuro-oncology at Brigham and Women’s Hospital/Harvard University in Boston. She has also undertaken basic science research in Neuro-oncology at The Royal Melbourne Hospital and was awarded an MD from the University of Melbourne for this work in 2008. She is currently appointed as a Neurosurgeon at The Royal Melbourne Hospital and Associate Professor at the University of Melbourne. Her chief research and clinical interests are in the biology and management of brain tumours. Her research has been supported by a number of grants from both Australian and US granting bodies. She has published more than 50 peer reviewed articles, many book chapters and is frequently invited to speak nationally and internationally. (more...)

 

Catherine has recently returned from San Francisco, USA, where she was undertaking an international assignment at Genentech, Inc. as a Senior Clinical Program Leader in Clinical Operations Research and Early Development.

 

Dr Kathryn Field, MBBS(Hons), FRACP, DMedSc, MPH, is a medical oncologist. Since completing her training in 2008, she has been involved in clinical research related to brain tumours and bowel cancer. She completed her Masters of Public Health at Harvard University in 2013 as a Fulbright scholar and Frank Knox Memorial Fellow. Prior to this, she was awarded a postgraduate Doctor of Medical Science through the University of Melbourne, studying the use of patient factors and biomarkers to improve treatment and outcome for colorectal cancer and other malignancies. Kathryn is the principal investigator of the CABARET randomized phase II clinical trial for patients with brain tumors in Australia, having been involved with the trial from conception through to near-completion.

 

Dr John Fuller Dr John Fuller, MBBS FRACS, graduated from the University of New South Wales in 1987. He undertook neurosurgical training in Sydney at the Prince of Wales, Sydney Children’s and Prince Alfred Hospitals obtaining his RACS Fellowship in Neurosurgery in 1996. Since obtaining his fellowship he has practiced in Canberra managing all aspects of neurosurgery with a special interest in neuro-oncology.

Dr Fuller became a founding member of Macquarie Neurosurgery to combine his subspeciality interest in surgical neuro-oncology with radiosurgery as Neurosurgical Director of the Gamma Knife Surgery Program at Macquarie University Hospital, Sydney. He was Co-Chairman of the 16th Leksell Gamma Knife Society Meeting, Sydney, 2012. (more...)

 

Giuliana’s research interests are focused on the ethical issues arising in health practice and research. She is a longstanding member of several ethics committees and has designed and delivered education and training programs on research ethics and research methods for researchers and HREC members. Giuliana has published her academic work internationally and engaged in the public debate of ethical issues through local media.

 

In addition to his work as an academic radiologist, with interests in neurodegenerative diseases and imaging of CNS tumours, he is also the founder and editor in chief of Radiopaedia.org, the largest collaborative online radiology resource.

 

Dr Hui Gan is a medical oncologist, currently working at the Joint Austin Ludwig Oncology Unit, Austin Health (Melbourne, Australia). He graduated from Melbourne University in 1995 with a bachelor of medicine and surgery (MBBS). He became a Fellow of the Royal Australian College of Physicians in 2003. Thereafter, he obtained his PhD from Melbourne University for translational research focusing on the development of tumour-specific anti-EGFR antibodies with improved tumour targeting capability and reduced toxicity. He completed a Fellowship in Drug Development at the Princess Margaret Hospital (Toronto, Canada) in 2009 before returning to Melbourne, Australia. Currently, he is a medical oncologist at Austin Health where he specializes in head and neck cancer, primary brain tumours and phase I/II clinical trials. He holds a concurrent appointment as a senior clinical research fellow at the Ludwig Institute for Cancer Research where he pursues his interest in targeted agents against cancer, particularly monoclonal antibodies against EGFR and other member of the ErbB family.

 

Dr Eric Hau Dr Eric Hau is a radiation oncologist with interest in treating CNS disease at St George Hospital, Sydney. He graduated from UNSW in 2004 and subsequently trained in radiation oncology at St George as well as Crown Princess Mary Cancer Centre Westmead and Nepean Hospital. He is currently completing a PhD at the Lowy Cancer Research Centre. The title of the thesis is Overcoming Radiation Resistance with Metabolic Modulation of Glioblastomas.

A/Prof Ian Kerridge is Director and Associate Professor in Bioethics at the Centre for Values, Ethics and the Law in Medicine at the University of Sydney and Staff Haematologist/Bone Marrow Transplant physician at Royal North Shore Hospital, Sydney.  He is the author of over 250 papers in peer-reviewed journals and five textbooks of ethics, most recently Ethics and Law for the Health Professions (Federation Press, 2013) He is a member of the Australian Health Ethics Committee (AHEC), Chair of the Australian Bone Marrow Donor Registry Research Committee and a member of the NSW Health Department’s Clinical Ethics Advisory Panel. His current research interests in ethics include the philosophy of medicine, conflict of interest, stem cells, drug policy, end-of-life care, synthetic genomics, public health and organ donation.

 

Prof Khan (MBBS, MD, FAFRM (RACP)), a rehabilitation physician is Professorial Fellow at the Department of Medicine, University of Melbourne; and School of Public Health and Preventative Medicine, Monash University. She is also the Director of the Rehabilitation Services at the Royal Melbourne Hospital (RMH). She completed her specialist training with the Australasian Faculty of Rehabilitation Medicine, Royal Australasian College of Physicians in 2000 and in 2009, she was awarded ‘Doctor of Medicine’ from the University of Melbourne.  She is a Representative for the Western Pacific Region WHO, ICF Research Branch, Ludwig-Maximilian University and executive member of the WHO International Disaster Committee. She is Honorary Fellow of the National Aging and Research Institute and the Melbourne EpiCentre, Melbourne Health. She represents 9 public hospital networks in Victoria at the Clinical Leadership Group for the Care of the Older People, Department of Health Victoria (disability policy and planning). (more...)

 

Dr Mustafa Khasraw is the Clinical Lead of the Haematology and Oncology Clinical Trials at Andrew Love Cancer Centre in Geelong. He is a Medical Oncologist at Geelong and Royal Melbourne Hospitals. He acts at the NHMRC Clinical Trials Centre of The University of Sydney as a research fellow for the Cooperative Trials Group for Neuro-Oncology (COGNO). In addition, Dr Khasraw is a cancer research fellow at Deakin University with leading role in several clinical and translational laboratory programs. After his medical oncology training in Sydney he undertook an oncology fellowship training in the US at Memorial Sloan-Kettering Cancer Centre in New York. His fellowship was both in neuro-oncology and in breast cancer. He is a member of several committees including Barwon Health Research Review Committee, the Breast Cancer Network Australia's Strategic Advisory Group and the organising committees of 2012 MOGA annual scientific meeting (ASM), 2012 and 2013 COGNO ASM and the co-convenor of the 2014 COGNO ASM. He is leading several multi centre clinical trials and he has been the first author of numerous manuscripts and book chapters and he acts regularly as a reviewer for a number of scientific journals and grant review committees.

 

Prof Koczwara is the immediate past President of the Clinical Oncology Society of Australia (COSA), the peak cancer professional organisation in Australia and the past president of the Medical Oncology Group of Australia (MOGA), the national professional organisation of medical oncologists. She is the initiator and the immediate past Chair the Australia Asia Pacific Clinical Oncology Research Development, a collaborative of international cancer organisations aimed at improving cancer research capacity in Australia and Asia Pacific.

She is the current chair of the Clinical Oncological Society of Australia (COSA) Neuro-oncology group and is a member of the COGNO Scientific and Management Advisory Committees.

 

Born in the UK and originally destined for a life of academic historic language research at Manchester University, Marian diverted into the world of nursing in a momentary fit of wanting “to do something useful”. She completed her training at St Thomas” Hospital in London and then undertook specialist oncology training at the Royal Marsden. Marian moved to Melbourne – for a year- in 1986 – and has been here ever since! Her professional life has centred around the Oncology / Haematology units of the Royal Melbourne Hospital where she has worked in many areas. She moved into Clinical trials in 1989 for a 5 year stint and undertook the phase 1 GM and G-CSF trials, amongst other, during that time. The rapid arrival of 4 daughters and her husband’s post doc relocation to America, saw a move back into the mainstream clinical area, working in Chemotherapy ambulatory care and Apheresis. Marian returned to Clinical Trials in 2004 and since then has managed the ever growing Cancer Clinical Trials Unit at the Royal Melbourne. She was a founding member of the Victorian Research Nurses Association and deputy Chair of the Cancer Council’s Research Professionals group. Marian believes that every patient should have access to the best clinical trials and that they deserve expert nursing care whilst participating in them, and, to that end, has been actively involved in getting Research Nursing recognised as a specialist branch of nursing in Victoria.

 

Dr Victor Loh graduated from the University of Sydney with a Bachelor of Medicine and Bachelor of Surgery and obtained his Master of Business Administration from the University of Melbourne through the Universitas 21 Global Graduate School program. He worked in clinical medicine in Malaysia for over five years before starting his pharmaceutical career with sanofi-aventis Malaysia. Victor then spent 6 years with Bayer in various roles across 3 countries, moving from Malaysia to Australia and to the regional office in Singapore. He has been with Novartis Oncology Australia as Head of Medical for Solid Tumours since February 2012.

 

Professor Mark Rosenthal trained as a Medical Oncologist in Melbourne and Sydney, Australia. He was awarded a Doctorate of Philosophy for a thesis examining the molecular genetics of colon cancer conducted at the Ludwig Institute for Cancer Research. (1992-1996). He completed post-graduate training at New York University Medical Centre, New York, USA (1996-98) and was appointed as a Senior Staff Specialist in the Department of Medical Oncology, Royal Melbourne Hospital in 1998. In 2006, he was appointed Professor Director of the Department. In addition, he is Chairman and Chief Medical Officer of Cancer Trials Australia and is Chairman of the Cooperative Trials Group for Neuro-Oncology (COGNO). His major interests include: prostate cancer, neuro-oncology and early phase clinical trials.